Importantly, this knowledge will—in the long term—be the key to exploiting a potential modulation of AATF in the clinical setting with a focus on cancer, cardiovascular disease, and organ protection from genotoxic and oxidative stress. The gene discussed is AATF; the disease is cardiovascular disorder.